“…Thirdly, reliance on proving the null hypothesis to be false may offer perverse trial design incentives, lead to publication bias and may even distort the scientific record [5]. Fourthly, non-significance is often conflated with evidence for a lack of effect or non-inferiority [6]. Finally, patients are rarely interested in whether the benefit from a proposed treatment was probably 'not due to chance' in a randomly selected sample; they simply want to know if it is effective for them [7].…”